A bi-specific antibody molecule is the basis for a new strategy to kill HIV-infected cells, as described in a Journal of Clinical Investigation article from M&I Professor David Margolis and colleagues. See the story at the link below.
A bi-specific antibody molecule is the basis for a new strategy to kill HIV-infected cells, as described in a Journal of Clinical Investigation article from M&I Professor David Margolis and colleagues. See the story at the link below.